Annual Securities Report — FY2024
What Chordia Therapeutics Inc. reported for the period from 2024-09-01 to 2025-08-31. Filed by Chordia Therapeutics, Inc.
Filed 2025-11-21View the original on EDINET
Period coveredFY20242024-09-01 → 2025-08-31
Which filing this is
4/ 5
Filed2025-11-21
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
This document has not been read in full yet. What you see below comes straight from the filing itself. Once it is read, the point, what to read, and their words are added.
R&D spend14億円Money spent making new things.
Cash left over-18億円Cash from the business, less what went into equipment.
Spent on equipment0百万円Plants, machines — things meant to last.
Employees20Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.